Works matching AU Namayanja, Monica

Results: 3

Quantitative expression of estrogen, progesterone and human epidermal growth factor receptor-2 and their correlation with immunohistochemistry in breast cancer at Uganda Cancer Institute.
Published in:
PLoS ONE, 2025, v. 20, n. 1, p. 1, doi. 10.1371/journal.pone.0311185
By:
- Wannume, Henry;
- Niyonzima, Nixon;
- Kalungi, Sam;
- Okuni, Julius Boniface;
- Okecha, Tonny;
- Kakungulu, Edward;
- Kiwuwa, Steven Mpungu;
- Waiswa, Geoffrey;
- Kadhumbula, Sylvester;
- Namayanja, Monica;
- Nabwana, Martin;
- Orem, Jackson
Publication type:
Article
Immunological and biochemical biomarker alterations among SARS-COV-2 patients with varying disease phenotypes in Uganda.
Published in:
BMC Infectious Diseases, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12879-023-08854-0
By:
- Kato, Charles Drago;
- Nsubuga, Julius;
- Niyonzima, Nixon;
- Kitibwa, Annah;
- Matovu, Enock;
- Othieno, Emmanuel;
- Ssebugere, Patrick;
- Tumwine, Amanda Agnes;
- Namayanja, Monica
Publication type:
Article
Retrospective in silico mutation profiling of SARS-CoV-2 structural proteins circulating in Uganda by July 2021: Towards refinement of COVID-19 disease vaccines, diagnostics, and therapeutics.
Published in:
PLoS ONE, 2022, v. 17, n. 12, p. 1, doi. 10.1371/journal.pone.0279428
By:
- Odongo, Steven;
- Okella, Hedmon;
- Ndekezi, Christian;
- Okee, Moses;
- Namayanja, Monica;
- Mujuni, Brian;
- Sterckx, Yann G. J.;
- Kizito, Dennison;
- Radwanska, Magdalena;
- Magez, Stefan;
- Ikwap, Kokas;
- Mwiine, Frank Nobert;
- Lutwama, Julius Julian;
- Ibingira, Charles
Publication type:
Article

Works matching AU Namayanja, Monica

Quantitative expression of estrogen, progesterone and human epidermal growth factor receptor-2 and their correlation with immunohistochemistry in breast cancer at Uganda Cancer Institute.

Immunological and biochemical biomarker alterations among SARS-COV-2 patients with varying disease phenotypes in Uganda.

Retrospective in silico mutation profiling of SARS-CoV-2 structural proteins circulating in Uganda by July 2021: Towards refinement of COVID-19 disease vaccines, diagnostics, and therapeutics.